Evaluation of changes in antimicrobial susceptibility patterns of Pasteurella multocida subsp multocida isolates from pigs in Spain in 1987-1988 and 2003-2004

American Journal of Veterinary Research

Volumn 67, Issue 4, 2006, Pages 663-668

  Vera Lizarazo, Yanedt A ^a   Rodríguez Ferri, Elías F ^a   Martín de la Fuente, A Judith ^a   Gutiérrez Martín, César B ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; APRAMYCIN; CEFTIOFUR; CHLORTETRACYCLINE; CLINDAMYCIN; COTRIMOXAZOLE; ENROFLOXACIN; ERYTHROMYCIN; FLORFENICOL; GENTAMICIN; NEOMYCIN; OXYTETRACYCLINE; PENICILLIN G; SPECTINOMYCIN; SULFACHLORPYRIDAZINE; SULFADIMETHOXINE; SULFATHIAZOLE; SULFONAMIDE; TIAMULIN; TILMICOSIN; TYLOSIN TARTRATE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG CONTRAINDICATION; FREQUENCY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PASTEURELLA MULTOCIDA; SENSITIVITY ANALYSIS; SPAIN; SWINE DISEASE; TIME SERIES ANALYSIS; ANIMAL; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SWINE;

PASTEURELLA MULTOCIDA;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PASTEURELLA MULTOCIDA; SULFONAMIDES; SWINE;

EID: 33646831496     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.4.663     Document Type: Article

References (40)

1. Blackall PJ, Fegan N, Pahoff JL, et al. The molecular epidemiology of four outbreaks of porcine pasteurellosis. Vet Microbiol 2000;72:111-120.
2. Gois M, Barnes HJ, Ross RF. Potentiation of turbinate atrophy in pigs by long-term nasal colonization with Pasteurella multocida. Am J Vet Res 1983;44:372-378.
3. Mutters R, Ihm P, Pohl S, et al. Reclassification of the genus Pasteurella Trevisan 1887 on the basis of deoxyribonucleic acid homology, with proposals for the new species Pasteurella dagmatis, Pasteurella canis, Pasteurella stomatis, Pasteurella anatis, and Pasteurella langaa. Int J Syst Bacteriol 1985;35:309-322.
4. Avril JL, Donnio PY, Pouedras P. Selective medium for Pasteurella multocida and its use to detect oropharyngeal carriage in pig breeders. J Clin Microbiol 1990;28:1438-1440.
5. Larivière S, Leblanc L, Mittal KR, et al. Characterization of Pasteurella multocida from nasal cavities of piglets from farms with or without atrophic rhinitis. J Clin Microbiol 1992;30:1398-1401.
6. Townsend KM, Boyce JD, Chung JY, et al. Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system. J Clin Microbiol 2001;39:924-929.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility test for bacteria isolated from animals: informational supplement, NCCLS document M31-A2. Wayne, Pa: NCCLS, 2004.
8. Gutiérrez CB, Píriz S, Vadillo S, et al. In vitro susceptibility of Actinobacillus pleuropneumoniae strains to 42 antimicrobial agents. Am J Vet Res 1993;54:546-550.
9. Chang CF, Yeh TM, Chou CC, et al. Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan. Vet Microbiol 2002;84:169-177.
10. Vela AI, Moreno MA, Cebolla JA, et al. Antimicrobial susceptibility of clinical strains of Streptococcus suis isolated from pigs in Spain. Vet Microbiol 2005;105:143-147.
11. Craig WA. Qualitative susceptibility tests versus quantitative MIC tests. Diagn Microbiol Infect Dis 1993;16:231-236.
12. Background document for the Joint WHO/FAO/OIE Expert Workshop on Non-human Antimicrobial Usage and Antimicrobial Resistance: scientific assessment, Geneva, Switzerland, 1-5 December 2003. Available at: www.who.int/foodsafety/publications/micro/en/background.pdf. Accessed Feb 7, 2006.
13. US FDA. Center for Veterinary Medicine. The Green Book. Available at: www.fda.gov/com/Green_Book/greenbook.html. Accessed Oct 14, 2005.
14. FDA bans animal antibiotic Baytril. Available at:www.npr.org/templates/story/story.php?storyId=4777277. Accessed Oct 14, 2005.
15. Yamamoto J, Sakano T, Shimizu M. Drug resistance and R plasmids in Pasteurella multocida isolates from swine. Microbiol Immunol 1990;34:715-721.
16. Gutiérrez Martín CB, Rodríguez Ferri EF. In vitro susceptibility of Pasteurella multocida subspecies multocida strains isolated from swine to 42 antimicrobial agents. Zentralbl Bakteriol 1993;279:387-393.
17. Salmon SA, Watts JL, Case CA, et al. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. J Clin Microbiol 1995;33:2435-2444.
18. Hormansdorfer S, Bauer J. Resistance of bovine and porcine Pasteurella to florfenicol and other antibiotics [German]. Berl Munch Tierarztl Wochenschr 1998;111:422-426.
19. Chang WH, Carter GR. Multiple drug resistance in Pasteurella multocida and Pasteurella haemolytica from cattle and swine. J Am Vet Med Assoc 1976;169:710-712.
20. Raemdonck DL, Tanner AC, Tolling ST, et al. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella cholerasuis isolates from pigs. Vet Rec 1994;134:5-7.
21. Yoshimura H, Ishimaru M, Endoh YS, et al. Antimicrobial susceptibility of Pasteurella multocida isolated from cattle and pigs. J Vet Med B Infect Dis Vet Public Health 2001;48:555-560.
22. Diarra MS, Malouin F, Jacques M. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens. Int J Antimicrob Agents 1999; 12:229-237.
23. Hansen LM, Blanchard PC, Hirsh DC. Distribution of tet(H) among Pasteurella isolates from the United States and Canada. Antimicrob Agents Chemother 1996;40:1558-1560.
24. Kehrenberg C, Salmon SA, Watts JL, et al. Tetracycline resistance genes in isolates of Pasteurella multocida, Mannheimia haemolytica, Mannheimia glucosida and Mannheimia varigena from bovine and swine respiratory disease: intergeneric spread of the tet(H) plasmid pMHT1. J Antimicrob Chemother 2001;48:631-640.
25. Bousquet E, Morvan H, Aitken I, et al. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens. Vet Rec 1997;141:37-40.
26. Inamoto T, Kikuchi K, Iijima H, et al. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine. J Vet Med Sci 1994;56:917-921.
27. Cote S, Harel J, Higgins R, et al. Resistance to antimicrobial agents and prevalence of R plasmids in Pasteurella multocida from swine. Am J Vet Res 1991;52:1653-1657.
28. Kirst HA, Ose EE, Toth JE, et al. In vitro and in vivo evaluation of C-20- and C-23- modified derivatives of tylosin against veterinary pathogens. J Antibiot (Tokyo) 1988;41:938-948.
29. Hannan PC, Bhogal BS, Fish JP. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res Vet Sci 1982;33:76-88.
30. Moore GM, Basson RP, Tonkinson LV. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. Am J Vet Res 1996;57:224-228.
31. DeRosa DC, Veenhuizen MF, Bade DJ, et al. In vitro susceptibility of porcine respiratory pathogens to tilmicosin. J Vet Diagn Invest 2000;12:541-546.
32. Mengelers MJ, van Klingeren B, van Miert AS. In vitro antimicrobial activity of sulfonamides against some porcine pathogens. Am J Vet Res 1989;50:1022-1028.
33. Mengelers MJ, van Klingeren B, van Miert AS. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents. Am J Vet Res 1990;51:1860-1864.
34. Kehrenberg C, Schulze-Tanzil G, Martel JL, et al. Antimicrobial resistance in Pasteurella and Mannheimia: epidemiology and genetic basis. Vet Res 2001;32:323-339.
35. Kehrenberg C, Tham NT, Schwarz S. New plasmid-borne antibiotic resistance gene cluster in Pasteurella multocida. Antimicrob Agents Chemother 2003;47:2978-2980.
36. Priebe S, Schwarz S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob Agents Chemother 2003;47:2703-2705.
37. Shin SJ, Kang SG, Nabin R, et al. Evaluation of the antimicrobial acitivity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Vet Microbiol 2005;106:73-77.
38. Kehrenberg C, Schwarz S. Plasmid-borne florfenicol resistance in Pasteurella multocida. J Antimicrob Chemother 2005; 55:773-775.
39. Jones RN, Pfaller MA, Rhomberg PR, et al. Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods. J Clin Microbiol 2002;40:461-465.
40. Burch DG, Jones GT, Heard TW, et al. The synergistic activity of tiamulin and chlortetracycline: in-feed treatment of bacterially complicated enzootic pneumonia in fattening pigs. Vet Rec 1986;119:108-112.